GlassScriptPhysician profile
Jenny A Templet
NPI 1124236658
$5,797.76
in general payments reported to CMS, 2019-2025
41 companies · $593 in 2025
The $593 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $424 · 2021: $1,004 · 2022: $1,016 · 2023: $1,119 · 2024: $756 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,647.88 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $521.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $518.83 | 2020-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Kowa Pharmaceuticals America, INC. | $323.67 | 2019-2025 | Livalo, Zoryve, Seglentis |
| Lilly USA, LLC | $313.82 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Allergan, INC. | $261.61 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $253.81 | 2019-2023 | Breztri, Farxiga |
| Amgen INC. | $247.86 | 2019-2024 | Otezla, Repatha |
| Novo Nordisk INC | $201.72 | 2019-2025 | Rybelsus, Ozempic, Saxenda |
| Merck Sharp & Dohme LLC | $177.40 | 2019-2024 | Dificid, Pifeltro, Gardasil |
| Janssen Pharmaceuticals, INC | $132.59 | 2019-2022 | |
| Exact Sciences Corporation | $90.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $89.14 | 2021-2023 | Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.02 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $76.18 | 2019-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Templet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.